Verdict Medical Devices

Metrion introduces NaV1.9 screening assay for pain therapeutic development

Metrion has launched the NaV1.9 screening assay, aimed at progressing the discovery along with the development of new pain therapeutics. The post Metrion introduces NaV1.9 screening assay for pain therapeutic development appeared first on Medical Device Network.

Apr 29, 2025 - 16:35
 0
Metrion introduces NaV1.9 screening assay for pain therapeutic development
Metrion has launched the NaV1.9 screening assay, aimed at progressing the discovery along with the development of new pain therapeutics.

The post Metrion introduces NaV1.9 screening assay for pain therapeutic development appeared first on Medical Device Network.

Read More

Tags:

Previous Article

EOS launches Medical Device Master File to streamline regulatory approval processes

Next Article

Power restoration underway after major outage in Spain and Portugal

Related Posts

Medtronic’s defibrillation lead gains FDA approval for use in right ventricle

Medtronic’s defibrillation lead gains FDA approval for ...

Apr 28, 2025  0

Intravascular lithotripsy: Reducing the risk of heart attacks and strokes

Intravascular lithotripsy: Reducing the risk of heart a...

Apr 23, 2025  0

Epiminder’s implantable EEG system for epilepsy receives FDA authorisation

Epiminder’s implantable EEG system for epilepsy receive...

Apr 23, 2025  0